Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,207 public trials 1,003 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Active, Not Recruiting

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies

NCT04644068

Conditions
Additional Indications Below for Module 4 and 5, Adnexal Diseases, Biliary Cancer, +66 more
Locations
  • Research Site Boston, Massachusetts, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site New York, United States
  • Research Site Oklahoma City, Oklahoma, United States
View all 68 locations
View Trial Details
Active, Not Recruiting

Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)

NCT03767348

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
Locations
  • University of Birmingham Alabama Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • Carti Cancer Center Little Rock, Arkansas, United States
View all 51 locations
View Trial Details
Active, Not Recruiting

Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer

NCT04665856

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations
  • Beijing Cancer Hospital Beijing, China
  • Beijing Chest Hospital Beijing, China
  • the First Affiliated Hospital of Bengbu Medical College Bengbu, China
  • the First Hospital of Jilin University Changchun, China
View all 16 locations
View Trial Details
Active, Not Recruiting

Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC)

NCT05186974

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Alaska Oncology and Hematology, LLC. Anchorage, Alaska, United States
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Hematology/Oncology - Santa Monica Los Angeles, California, United States
View all 101 locations
View Trial Details
Active, Not Recruiting

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

NCT05863052

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +46 more
Locations
  • Arizona Cancer Center at the Unvieristy of Arizona Tucson, Arizona, United States
  • University of New Mexico Comprehensive Cancer Center Albuquerque, New Mexico, United States
  • Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Monument Health Cancer Care Institute Rapid City, South Dakota, United States
View Trial Details
Active, Not Recruiting

Immunotherapy, Chemotherapy, Radiotherapy and Surgery for Synchronous Oligo-metastatic NSCLC

NCT03965468

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • European Institute of Oncology Milan, Italy
  • Istituto Oncologico Veneto - Irccs Padova, Italy
  • IRCCS Istituto Nazionale Tumori Regina Elena Roma, Italy
  • Maastricht University Medical Center Maastricht, Netherlands
View all 15 locations
View Trial Details
Active, Not Recruiting

Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors

NCT05479812

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +37 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • Northwestern University Chicago, Illinois, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors

NCT05239143

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Cancer, +66 more
Locations
  • University of California, Irvine Medical Center Irvine, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • University of California, San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 14 locations
View Trial Details

Related conditions